Thanks to the extraordinary support and engagement of the Down syndrome community, LuMind IDSC is celebrating a year of outstanding progress. In accelerating research, expanding connections, raising voices, and influencing […]
This video discusses the repurposing existing drugs and therapies for new uses. Source: Massachusetts Down Syndrome Congress
Growing evidence has suggested that Type I Interferon (I-IFN) plays a potential role in the pathogenesis of Down Syndrome (DS).Source: Guo et al.
In this webinar, Dr. Michael Rafii joins the National Down Syndrome Society (NDSS) to discuss the latest understanding of Alzheimer’s disease, recent advances in diagnostic tests and treatments for Alzheimer’s […]
Thyroid dysfunction stands as the most prevalent endocrine disorder in individuals with Down syndrome, particularly showcasing both clinical and subclinical hypothyroidism. The objective of this study was to analyze the […]
This article gives an overview of Down syndrome for professionals.Source: Merck
